The latest lymphoma news
New resource to help families understand paediatric Hodgkin lymphoma
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of NCCN Guidelines for Patients®: Hodgkin Lymphoma…
Browsing: Lymphoma
Adding immunity to human kidney-on-a-chip advances cancer drug testing
A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new…
Researchers develop novel approach for predicting resistance against cancer therapy
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University…
Cell therapy shows promise for patients with relapsed leukaemia
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission…
Practice changing global clinical trial for advanced-stage Hodgkin lymphoma achieves major results for patients
Patient outcomes from an international cooperative clinical trial for advanced stage Hodgkin lymphoma show “the…
FDA grants accelerated approval to glofitamab-gxbm for selected relapsed or refractory large B-cell lymphomas
The Food and Drug Administration has granted accelerated approval to glofitamab-gxbm for relapsed or refractory…
LP-284 targets non-Hodgkin’s lymphoma and DNA damage repair deficiency
A new research paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “LP-284, a…
Clinical trial shows newly approved drug’s potential for rare B-cell lymphoma
In a multicenter phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers…
New data informs treatment of blood cancer during pregnancy
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a…
ASCO 2023: Axi-cel improves survival in early large B-cell lymphoma
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…